Melanoma accounts for 1.7% of global cancer diagnoses and is the fifth most common
cancer in the US. Melanoma incidence is rising in developed, predominantly fair-skinned …

… melanomas of mucosal and uveal origin occurring more rarely (<1–5% of diagnoses, with
country-specific variation). Cutaneous melanomas (… Although most cutaneous melanomas are …

… , cutaneous melanoma was rare; in 1935, a person’s lifetime risk of developing melanoma
… 2 Now, in the Western population, one in 50 individuals will develop melanoma. 3 Over the …

… for melanoma. Radiation therapy can play an integral role in the treatment of a subset of canine
and feline melanomas. … of canine and feline melanomas. Immunotherapy represents one …

… in advanced melanoma, and has high activity in melanoma brain … for patients with advanced
melanoma. Immune checkpoint … stage III or IV melanoma. Neoadjuvant checkpoint inhibition …

… nevus syndrome, with familial melanoma or familial melanoma syndromes; on the … melanoma,
especially in case of sunburns in pediatric age. This review aims to summarize melanoma …

… be 106,110 new cases of invasive melanoma with 7,180 melanoma-related deaths in the …
cases of melanoma worldwide, representing 1.7% of all cancers and 57,043 melanoma deaths …

… for melanoma therapy. In this review, we firstly make a brief introduction to melanoma
epidemiology, … Then, the signal pathways orchestrating melanoma pathogenesis, including …

… melanoma field has seen an unprecedented set of clinical advances over the past decade.
Therapeutic efficacy for advanced or metastatic melanoma … of advanced melanoma and also …

… the formation of melanoma from skin melanocytes, the molecular events involved in
melanoma growth and metastasis, and the biology underlying resistance to melanoma therapies. …